Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Kuramitsu

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
The Tohoku Journal of Experimental Medicine|October 1, 1992
Augmented accumulation of transferred lymphokine-activated killer (LAK) cells at murine tumor sites through production of LAK-attractant facilitated by chemotherapyM Hosokawa, Y Wakizaka, Y Kuramitsu, et al.
Journal of Food Protection|November 3, 1998
Rapid detection and counting of viable bacteria in vegetables and environmental water using a photon-counting TV cameraT Miyamoto, Y Kuramitsu, A Ookuma, et al.
International Journal of Oncology|May 6, 2011
HLA class I antigens are possible prognostic factors in hepatocellular carcinomaM Nishibe, Y Une, M Kobayashi, et al.
Cancer Immunology, Immunotherapy : CII|December 9, 1997
Restoration of macrophage tumoricidal activity by bleomycin correlates with the decreased production of transforming growth factor beta in rats bearing KDH-8 hepatoma cellsL Yuan, M Kobayashi, Y Kuramitsu, et al.
Anti-Cancer Drugs|November 21, 1998
ND-2001 suppresses lung metastasis of human renal cancer cells in athymic miceY Kuramitsu, J Hamada, T Tsuruoka, et al.
Anti-Cancer Drugs|June 23, 1998
Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinomaK Matsushita, Y Kuramitsu, Y Ohiro, et al.
Radiation Research|June 9, 1999
The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing ratsS Hashimoto, H Shirato, M Hosokawa, et al.
British Journal of Cancer|July 1, 1996
Transforming growth factor beta 1 (TGF-beta 1) produced in tumour tissue after chemotherapy acts as a lymphokine-activated killer attractantY Kuramitsu, M Nishibe, M Kobayashi, et al.
Anti-Cancer Drugs|June 1, 1997
A new synthetic lipid A analog, ONO-4007, stimulates the production of tumor necrosis factor-alpha in tumor tissues, resulting in the rejection of transplanted rat hepatoma cellsY Kuramitsu, M Nishibe, Y Ohiro, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 1, 1997
Enhancement of lymphokine-activated killer cell activity by fibronectinY Q Li, M Kobayashi, Y Kuramitsu, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
The Tohoku Journal of Experimental Medicine|October 1, 1992
Augmented accumulation of transferred lymphokine-activated killer (LAK) cells at murine tumor sites through production of LAK-attractant facilitated by chemotherapyM Hosokawa, Y Wakizaka, Y Kuramitsu, et al.
Journal of Food Protection|November 3, 1998
Rapid detection and counting of viable bacteria in vegetables and environmental water using a photon-counting TV cameraT Miyamoto, Y Kuramitsu, A Ookuma, et al.
International Journal of Oncology|May 6, 2011
HLA class I antigens are possible prognostic factors in hepatocellular carcinomaM Nishibe, Y Une, M Kobayashi, et al.
Cancer Immunology, Immunotherapy : CII|December 9, 1997
Restoration of macrophage tumoricidal activity by bleomycin correlates with the decreased production of transforming growth factor beta in rats bearing KDH-8 hepatoma cellsL Yuan, M Kobayashi, Y Kuramitsu, et al.
Anti-Cancer Drugs|November 21, 1998
ND-2001 suppresses lung metastasis of human renal cancer cells in athymic miceY Kuramitsu, J Hamada, T Tsuruoka, et al.
Anti-Cancer Drugs|June 23, 1998
Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinomaK Matsushita, Y Kuramitsu, Y Ohiro, et al.
Radiation Research|June 9, 1999
The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing ratsS Hashimoto, H Shirato, M Hosokawa, et al.
British Journal of Cancer|July 1, 1996
Transforming growth factor beta 1 (TGF-beta 1) produced in tumour tissue after chemotherapy acts as a lymphokine-activated killer attractantY Kuramitsu, M Nishibe, M Kobayashi, et al.
Anti-Cancer Drugs|June 1, 1997
A new synthetic lipid A analog, ONO-4007, stimulates the production of tumor necrosis factor-alpha in tumor tissues, resulting in the rejection of transplanted rat hepatoma cellsY Kuramitsu, M Nishibe, Y Ohiro, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 1, 1997
Enhancement of lymphokine-activated killer cell activity by fibronectinY Q Li, M Kobayashi, Y Kuramitsu, et al.
Pageof 5